Atorvastatin induces G0/G1 phase cell cycle arrest in colorectal cancer cells, activates apoptosis-related proteins, suppresses inflammatory cytokines (IL-1β, IL-6, TNF-α), and downregulates the EGFR/RhoA signaling pathway, thereby exerting anticancer effects. The gene discussed is EGFR; the disease is colorectal cancer.